Market Place
Sourcing Support
BioNTech posts overall survival data on would-be Keytruda killer
11 Dec 2024 //
FIERCE BIOTECH
BioNTech buys China`s Biotheus to support oncology strategy
14 Nov 2024 //
GLOBENEWSWIRE
BioNTech`s COVID vaccine sales surpassed expectations in Q3
05 Nov 2024 //
FIERCE PHARMA
BioNTech Reports Q3 2024 Results and Corporate Update
04 Nov 2024 //
GLOBENEWSWIRE
BioNTech lowers full-year revenue outlook on COVID-19 seasonality
04 Nov 2024 //
REUTERS
BioNTech to Host Innovation Series R&D Day on November 14, 2024
31 Oct 2024 //
GLOBENEWSWIRE
BioNTech Reports Q3 2024 Results And Corporate Update On November 4
21 Oct 2024 //
GLOBENEWSWIRE
FDA puts partial hold on BioNTech-OncoC4 phase 3 trial
19 Oct 2024 //
FIERCE BIOTECH
Novavax Receives EU Authorization For Updated COVID Vaccine
09 Oct 2024 //
REUTERS
Pfizer, BioNTech win bid to invalidate CureVac`s vaccine patents
08 Oct 2024 //
REUTERS
BioNTech Highlights AI Capabilities and R&D at Inaugural AI Day
02 Oct 2024 //
PRESS RELEASE
BioNTech Highlights AI Capabilities & R&D Use at Inaugural AI Day
01 Oct 2024 //
GLOBENEWSWIRE
CHMP Backs Pfizer-BioNTech`s Omicron COVID-19 Vaccine
20 Sep 2024 //
GLOBENEWSWIRE
BioNTech to Host AI Day on October 1, 2024
17 Sep 2024 //
GLOBENEWSWIRE
BioNTech To Present Clinical Data Updates At ESMO Congress
05 Sep 2024 //
GLOBENEWSWIRE
Tempus Announces Real World Data Collaboration with BioNTech
04 Sep 2024 //
BUSINESSWIRE
Duality Plans Hong Kong IPO To Fund BioNTech-Partnered ADC Trials
27 Aug 2024 //
FIERCE BIOTECH
Pfizer-BioNTech COVID-19 Vaccine Gets FDA Approval & Authorization
23 Aug 2024 //
BUSINESSWIRE
US FDA approves updated COVID shots ahead of fall and winter
22 Aug 2024 //
REUTERS
BioNTech says FDA lifts partial hold on its cancer drug trial
20 Aug 2024 //
REUTERS
FDA allows BioNTech-MediLink ADC trial to resume with lower, safer doses
19 Aug 2024 //
FIERCE BIOTECH
Pfizer, BioNTech’s Mixed Phase III Data Sets Back COVID-Flu Vaccine Candidate
19 Aug 2024 //
BIOSPACE
Pfizer/BioNTech`s Combo Flu Shot Defeated By Influenza Strain B
16 Aug 2024 //
FIERCE BIOTECH
Penn accuses BioNTech of skimping out on Comirnaty-related royalties in lawsuit
07 Aug 2024 //
FIERCE PHARMA
BioNTech Announces Second Quarter 2024 Financial Results and Corporate Update
05 Aug 2024 //
GLOBENEWSWIRE
BioNTech ends work on Genmab-partnered bispecific antibody acasunlimab
05 Aug 2024 //
FIERCE BIOTECH
BioNTech losses quadruple in Q2 amid shift to cancer drugs
05 Aug 2024 //
REUTERS
Genmab Takes Full Control of Acasunlimab Development Program
03 Aug 2024 //
GLOBENEWSWIRE
Moderna cuts 2024 sales forecast, sees low EU vaccine revenue into 2026
01 Aug 2024 //
REUTERS
BioNTech Reports Positive Phase 2 Results For BNT111 In Melanoma
30 Jul 2024 //
GLOBENEWSWIRE
BioNTech, Regeneron`s mRNA Cancer Candidate Wins In Phase 2 Trial
30 Jul 2024 //
FIERCE BIOTECH
BioNTech signs 3D printing deal to develop oral RNA drugs
24 Jul 2024 //
ENDPTS
BioNTech To Report Q2 2024 Results And Corporate Update August 5
22 Jul 2024 //
GLOBENEWSWIRE
CureVac Updates On Patent Litigation Trial Dates Against Pfizer/BioNTech
11 Jul 2024 //
ACCESSWIRE
Pfizer, BioNTech Get Positive CHMP Opinion for Omicron JN.1 COVID-19 Vaccine
27 Jun 2024 //
BUSINESSWIRE
Pfizer and BioNTech Receive CHMP Opinion for Omicron JN.1 COVID-19 Vaccine
27 Jun 2024 //
GLOBENEWSWIRE
BioNTech and DualityBio earn FDA Fast Track Designation for Prostate Cancer.
24 Jun 2024 //
GLOBENEWSWIRE
FDA halts BioNTech ADC trial over `significant risk of illness`
18 Jun 2024 //
FIERCE PHARMA
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
15 Jun 2024 //
REUTERS
FDA recommends updated Covid-19 vaccines targeting JN.1
06 Jun 2024 //
PHARMACEUTICAL TECHNOLOGY
BioNTech co-founder Özlem Türeci on ‘hip’ ADCs and the power of combo therapies
05 Jun 2024 //
ENDPTS
BioNTech, CEPI Expand Partnership For Africa mRNA Vaccine Ecosystem
29 May 2024 //
GLOBENEWSWIRE
BioNTech doubles down on ADC partner MediLink in new $1.8B biobucks pact
28 May 2024 //
ENDPTS
Medigene`s BioNTech Research Deal Extended Beyond Initial Term
21 May 2024 //
GLOBENEWSWIRE
BioNTech To Present Immunotherapy Updates At ASCO 2024
21 May 2024 //
GLOBENEWSWIRE
Medigene & BioNTech Extend T Cell Receptor Immunotherapy Collaboration
21 May 2024 //
CONTRACT PHARMA
Lyra to lay off 75% of its workers; Dupixent nears COPD decision
21 May 2024 //
ENDPTS
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
18 May 2024 //
REUTERS
BioNTech Shareholders Approve All 2024 AGM Agenda Items
17 May 2024 //
GLOBENEWSWIRE
BioNTech looks to 2026 for commercial debut in oncology
06 May 2024 //
FIERCE PHARMA
BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
06 May 2024 //
GLOBENEWSWIRE
Pfizer lifts profit view on cost cuts, demand for COVID products
02 May 2024 //
REUTERS
GSK launches mRNA patent infringement case against Pfizer
27 Apr 2024 //
FIERCE PHARMA
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
26 Apr 2024 //
REUTERS
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
23 Apr 2024 //
REUTERS
BioNTech Q1 2024 Results, Corporate Update May 6
22 Apr 2024 //
GLOBENEWSWIRE
Judge pauses Moderna`s infringement case against rival Pfizer
15 Apr 2024 //
FIERCE PHARMA
Ph 1 Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence
07 Apr 2024 //
GLOBENEWSWIRE
BioNTech gets US agency notice over default on COVID vaccine royalties
26 Mar 2024 //
REUTERS
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as CCO
20 Mar 2024 //
GLOBENEWSWIRE
